SCHEMBL8349299

SCHEMBL8349299

CC(C)C[C@H](NC(=O)c1ccc(-c2ccccc2)s1)C(=O)N1CC[C@@H]2[C@H]1C(=O)CN2C(=O)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSK P43235 6/20 0.70
CTSS P25774 4/20 0.52
HPGDS O60760 2/20 0.47
CCR1 P32246 1/20 0.41
CTSB P07858 1/20 0.40
CHRNA7 P36544 5/20 0.39
HTR3E A5X5Y0 4/20 0.39
HTR3B O95264 4/20 0.39
HTR3A P46098 4/20 0.39
HTR3D Q70Z44 4/20 0.39
HTR3C Q8WXA8 4/20 0.39
CTSV O60911 2/20 0.38
CTSL P07711 2/20 0.38
ACKR3 P25106 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044153 1.00 CTSK (0.70) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4043170 0.94 CTSK (0.63) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4045504 0.93 CTSK (0.61) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4046431 0.92 CTSK (0.60) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4045527 0.92 CTSK (0.60) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4039365 0.92 CTSK (0.59) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4042100 0.92 CTSK (0.59) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4042777 0.91 CTSK (0.57) CTSKCTSSHPGDSCTSBCHRNA7
SCHEMBL4043757 0.90 CTSK (0.57) CTSKCTSSHPGDSCCR1CTSB
SCHEMBL4044858 0.90 CTSK (0.57) CTSKCTSSHPGDSCTSBCHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed